Specific Practice & Industry Groups Details:
Statement of Practice Summary:
Antitrust; Competition Law; Banking Law; Finance; Business and Tort Litigation - USA; Business Restructuring; Reorganization; Capital Markets; Corporate Criminal Investigations; Employee Benefits; Executive Compensation; Energy; Environmental Law; Health Law; Safety; Financial Institutions Litigation; Regulation; Global Disputes; Government Regulation; Health Care; Insurance Recovery; Intellectual Property; Issues; Appellate Practice; Labor and Employment; Life Sciences; Mergers and Acquisitions; Private Equity; Projects and Infrastructure; Real Estate; Securities Litigation; SEC Enforcement; Tax Law.
Documents by Lawyers at this office
FDA Releases Framework for Overseeing Laboratory Developed Tests
Laurie A. Clarke,Brigid C. DeCoursey,Colleen Heisey, October 16, 2014
On September 30, 2014, the U.S. Food and Drug Administration ("FDA") released the two draft guidance documents setting forth FDA's proposed framework for regulating Laboratory Developed Tests ("LDTs") as medical devices: (i) Draft Guidance for Industry, Food and Drug...
Supreme Court Denies Cert in Herb Reed: Circuits to Remain Out of Tune as to Presumption of Irreparable Harm
John G. Froemming,Angela R. Gott,Candice M. Reder,Meredith M. Wilkes, October 16, 2014
The United States Supreme Court denied certiorari on October 6, 2014, in Herb Reed Enterprises, LLC v. Florida Entertainment Management, Inc., leaving trademark litigants uncertain as to whether to apply the traditional presumption of irreparable harm at the preliminary injunction stage.
Languages: Chinese (Cantonese), Dutch, Farsi, French, German, Gujarati, Hebrew, Hindi, Italian, Japanese, Kannada, Korean, Portuguese, and Spanish.